Barone I, Giordano C, Bonofiglio D, Andò S, Catalano S. The weight of obesity in breast cancer progression and metastasis: clinical and molecular perspectives. Semin Cancer Biol. 2020;60:274–84.
CAS PubMed Article Google Scholar
Hopkins BD, Goncalves MD, Cantley LC. Obesity and cancer mechanisms: cancer metabolism. J Clin Oncol. 2016;34(35):4277–83.
CAS PubMed PubMed Central Article Google Scholar
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults New England J Med. 2003;348(17):1625–38.
Dai H, Alsalhe TA, Chalghaf N, Riccò M, Bragazzi NL, Wu J. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990–2017: an analysis of the global burden of disease study. PLoS Med. 2020;17(7):e1003198.
PubMed PubMed Central Article Google Scholar
Specchia ML, Veneziano MA, Cadeddu C, Ferriero AM, Mancuso A, Ianuale C, et al. Economic impact of adult obesity on health systems: a systematic review. Eur J Public Health. 2014;25(2):255–62.
Anderson GL, Neuhouser ML. Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res. 2012;5(4):515–21.
Yoo K-Y, Tajima K, Park S-K, Kang D, Kim S-U, Hirose K, et al. Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan). Cancer Lett. 2001;167(1):57–63.
CAS PubMed Article Google Scholar
Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, et al. Obesity, body size, and risk of postmenopausal breast cancer: the women’s health initiative (United States). Cancer Causes Control. 2002;13(8):741–51.
Macciò A, Madeddu C. Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. Sci World J. 2011;11:806787.
John EM, Sangaramoorthy M, Phipps AI, Koo J, Horn-Ross PL. Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the san francisco bay area breast cancer study. Am J Epidemiol. 2010;173(2):201–16.
PubMed PubMed Central Article Google Scholar
Feingold KR. 2020. Obesity and Dyslipidemia. In: Kenneth R Feingold BA, Alison Boyce et al, editor. Adrenal Disease and Function: Endotext.
Yan J, Horng T. Lipid metabolism in regulation of macrophage functions. Trends Cell Biol. 2020;30(12):979–89.
CAS PubMed Article Google Scholar
Broadfield LA, Pane AA, Talebi A, Swinnen JV, Fendt S-M. Lipid metabolism in cancer: new perspectives and emerging mechanisms. Dev Cell. 2021;56(10):1363–93.
CAS PubMed Article Google Scholar
Cruz P, Mo H, McConathy W, Sabnis N, Lacko A. The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Front Pharmacol. 2013;4:119.
PubMed PubMed Central Article CAS Google Scholar
Gorin A, Gabitova L, Astsaturov I. Regulation of cholesterol biosynthesis and cancer signaling. Curr Opin Pharmacol. 2012;12(6):710–6.
CAS PubMed PubMed Central Article Google Scholar
Onwuka JU, Okekunle AP, Olutola OM, Akpa OM, Feng R. Lipid profile and risk of ovarian tumours: a meta-analysis. BMC Cancer. 2020;20(1):200.
CAS PubMed PubMed Central Article Google Scholar
Touvier M, Fassier P, His M, Norat T, Chan DS, Blacher J, et al. Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies. Br J Nutr. 2015;114(3):347–57.
CAS PubMed Article Google Scholar
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. (Eds.) AJCC (American Joint Committee on Cancer) Cancer Staging Manual (8th ed.). Springer; 2017.
Kim N-H, Song S, Jung S-Y, Lee E, Kim Z, Moon H-G, et al. Dietary pattern and health-related quality of life among breast cancer survivors. BMC Womens Health. 2018;18(1):65.
PubMed PubMed Central Article Google Scholar
Shin W-k, Song S, Jung S-Y, Lee E, Kim Z, Moon H-G, et al. The association between physical activity and health-related quality of life among breast cancer survivors. Health Qual Life Outcomes. 2017;15(1):132.
PubMed PubMed Central Article Google Scholar
Shin W-k, Song S, Hwang E, Moon H-G, Noh D-Y, Lee JE. Development of a FFQ for breast cancer survivors in Korea. British J Nutr. 2016;116(10):1781–6.
Shin W-K, Kim Z, Youn HJ, Cho J, Lee JE. Determinants of plasma 25-Hydroxyvitamin D concentrations among breast cancer survivors in Korea. Nutrients. 2018;10(3):380.
PubMed Central Article CAS Google Scholar
Youn J, Park S, Song S, Moon H-G, Noh D-Y, Jung S-Y, et al. Nutrient intakes from supplement and factors associated with supplement use among breast cancer survivors: A cross-sectional study. Eur J Cancer Care. 2021;30:e13447. https://doi.org/10.1111/ecc.13447.
Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DRJ, Tudor-Locke C, et al. 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575–81.
Organization WH. The Asia-Pacific perspective: Redefining obesity and its treatment: Regional Office of the Western Pacific (WPRO) World Health Organization. 2000.
Soininen P, Kangas AJ, Würtz P, Tukiainen T, Tynkkynen T, Laatikainen R, et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 2009;134(9):1781–5.
CAS PubMed Article Google Scholar
Inouye M, Kettunen J, Soininen P, Silander K, Ripatti S, Kumpula LS, et al. Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol. 2010;6(1):441.
PubMed PubMed Central Article Google Scholar
Soininen P, Kangas AJ, Würtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 2015;8(1):192–206.
CAS PubMed Article Google Scholar
Holmes MV, Millwood IY, Kartsonaki C, Hill MR, Bennett DA, Boxall R, et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol. 2018;71(6):620–32.
CAS PubMed PubMed Central Article Google Scholar
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
CAS PubMed Article Google Scholar
Kontush A. HDL particle number and size as predictors of cardiovascular disease. Front Pharmacol. 2015;6:218.
PubMed PubMed Central Article CAS Google Scholar
Watanabe H, Söderlund S, Soro-Paavonen A, Hiukka A, Leinonen E, Alagona C, et al. Decreased High-Density Lipoprotein (HDL) Particle Size, Preβ-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families. Arterioscler Thromb Vasc Biol. 2006;26(4):897–902.
CAS PubMed Article Google Scholar
Pascot A, Lemieux I, Prud’homme D, Tremblay A, Nadeau A, Couillard C, et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res. 2001;42(12):2007–14.
CAS PubMed Article Google Scholar
Tang H, Xiang Z, Li L, Shao X, Zhou Q, You X, et al. Potential role of anti-inflammatory HDL subclasses in metabolic unhealth/obesity. Artif Cells Nanomed Biotechnol. 2021;49(1):565–75.
PubMed Article CAS Google Scholar
Duparc T, Ruidavets J-B, Genoux A, Ingueneau C, Najib S, Ferrières J, et al. Serum level of HDL particles are independently associated with long-term prognosis in patients with coronary artery disease: the GENES study. Sci Rep. 2020;10(1):8138.
CAS PubMed PubMed Central Article Google Scholar
Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 2003;52(2):453–62.
CAS PubMed Article Google Scholar
Superko HR, Pendyala L, Williams PT, Momary KM, King SB, Garrett BC. High-density lipoprotein subclasses and their relationship to cardiovascular disease. J Clin Lipidol. 2012;6(6):496–523.
Dobiasova M, Stribrna J, Pritchard PH, Frohlich JJ. Cholesterol esterification rate in plasma depleted of very low and low density lipoproteins is controlled by the proportion of HDL2 and HDL3 subclasses: study in hypertensive and normal middle-aged and septuagenarian men. J Lipid Res. 1992;33(10):1411–8.
CAS PubMed Article Google Scholar
Ebbert JO, Jensen MD. Fat depots, free fatty acids, and dyslipidemia. Nutrients. 2013;5(2):498–508.
CAS PubMed PubMed Central Article Google Scholar
Assmann G, Nofer J-R. Atheroprotective effects of high-density lipoproteins. Annu Rev Med. 2003;54(1):321–41.
CAS PubMed Article Google Scholar
Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA. 2004;101(26):9774–9.
留言 (0)